“High-Frequency Migraine Refractory to Usual Pharmacological Treatment and Antibody and Responsive to Full-Spectrum Cannabidiol: A Case Report”. 2022. Headache Medicine 13 (3): 229-32. https://doi.org/10.48208/HeadacheMed.2022.26.